Back to Startups

brian_armstrong's anti-aging startup

About brian_armstrong's anti-aging startup

NewLimit is an anti-aging startup focused on epigenetic reprogramming, aiming to increase the healthy lifespan of individuals by genetically programming their cells.

Business Information
Target Customers
consumers healthcare providers research institutions
Industry Categories
Aging, Seniorcare Bioscience & Disease Personal Health
Business Model
Revenue Model B2C and B2B
Pricing Strategy Subscription-based and one-time fees for treatments
Sales Channels direct-to-consumer, partnerships with healthcare providers
Funding Timeline
Round Date Amount Investors
Series B May 06, 2025 $130.0M Unknown
Founders
b
brian_armstrong

CEO of Coinbase and Founder of NewLimit

Investors

No investor information available.

Recent Mentions
jeffjohnroberts
Jeff Roberts @jeffjohnroberts
May 06, 2025

Coinbase founder @brian_armstrong's anti-aging startup just raised a $130M Series B This emerging field of epigenetic reprogramming is fascinating stuff—and AI means it's advancing fast https://t.co/nm3q5135hm